-
公开(公告)号:PT98766B
公开(公告)日:1999-01-29
申请号:PT9876691
申请日:1991-08-23
Applicant: ABBOTT LAB
Inventor: CHU DANIEL T , PLATTNER JACOB J , HALLAS ROBERT
IPC: C07D455/03 , C07D498/06 , C07D498/16 , C07D513/06 , A61K31/44 , A61K31/47 , A61K31/495 , A61K31/50 , A61K31/535 , A61K31/54 , C07D221/04 , C07D221/22 , C07D279/36 , C07D471/06 , C07D513/00
-
公开(公告)号:GR3021342T3
公开(公告)日:1997-01-31
申请号:GR960402715
申请日:1996-10-16
Applicant: ABBOTT LAB
Inventor: CHU DANIEL TIM-WO , HALLAS ROBERT
IPC: A61K31/00 , A61K31/435 , A61K31/47 , A61K38/00 , A61P31/00 , A61P31/04 , C07D401/04 , C07D471/04 , C07K1/113 , C07K5/06 , C07K5/08 , C07K5/10 , C07K5/04
Abstract: 7-(3-A-amino-1-pyrrolidinyl) substituted naphthyridine and quinoline compounds wherein A is a solubilizing group selected from an amino acid residue or polypeptide chain.
-
公开(公告)号:AT141271T
公开(公告)日:1996-08-15
申请号:AT89117428
申请日:1989-09-21
Applicant: ABBOTT LAB
Inventor: CHU DANIEL TIM-WO , HALLAS ROBERT
IPC: A61K31/00 , A61K31/435 , A61K31/47 , A61K38/00 , A61P31/00 , A61P31/04 , C07D401/04 , C07D471/04 , C07K1/113 , C07K5/06 , C07K5/08 , C07K5/10 , C07K5/04 , C07D221/00
Abstract: 7-(3-A-amino-1-pyrrolidinyl) substituted naphthyridine and quinoline compounds wherein A is a solubilizing group selected from an amino acid residue or polypeptide chain.
-
公开(公告)号:DK466889D0
公开(公告)日:1989-09-21
申请号:DK466889
申请日:1989-09-21
Applicant: ABBOTT LAB
Inventor: CHU DANIEL TIM-WO , HALLAS ROBERT
IPC: A61K31/00 , A61K31/435 , A61K31/47 , A61K38/00 , A61P31/00 , A61P31/04 , C07D401/04 , C07D471/04 , C07K1/113 , C07K5/06 , C07K5/08 , C07K5/10
Abstract: 7-(3-A-amino-1-pyrrolidinyl) substituted naphthyridine and quinoline compounds wherein A is a solubilizing group selected from an amino acid residue or polypeptide chain.
-
公开(公告)号:IT8320510D0
公开(公告)日:1983-04-08
申请号:IT2051083
申请日:1983-04-08
Applicant: ABBOTT LAB
Inventor: TADANIER JOHN SOLOMAN , HALLAS ROBERT
IPC: A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/7036 , A61P31/04 , C07H15/224 , A61K
-
公开(公告)号:CA1022168A
公开(公告)日:1977-12-06
申请号:CA198886
申请日:1974-05-03
Applicant: ABBOTT LAB
Inventor: HALLAS ROBERT , MARTIN JERRY R , TADANIER JOHN S
IPC: A61K31/335 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08
Abstract: 1467296 Erythromycin derivatives ABBOTT LABORATORIES 1 May 1974 [4 May 1973] 19163/74 Heading C2C Novel erythromycin derivatives of the general formula wherein R is a C 1-6 alkyl, C 2-6 alkenyl, or optionally nuclear substituted aryl, benzyl or aroxyalkyl group, R 1 is a hydrogen atom or methyl group, R 2 is a hydrogen atom or C 1-6 alkanoyl group and R 3 is a hydrogen atom or hydroxyl group, provided that R 1 and R 3 are not simultaneously a hydrogen atom and the nuclear substituent is nitro, alkyl or halogen are prepared by reacting the corresponding compound in which the -OSO 2 R group is replaced by -OH with RSO 2 Cl (when R is vinyl in the product, R may be 2-bromoethyl in the starting material), followed optionally by hydrolysis or alcoholysis when R 2 is a C 1-6 alkanoyl group to give the corresponding product wherein R 2 is a hydrogen atom. Pharmaceutical compositions having antibiotic activity comprise, as active ingredient, an erythromycin derivative of the above general formula, together with an appropriate carrier.
-
公开(公告)号:DE69631609T2
公开(公告)日:2005-01-05
申请号:DE69631609
申请日:1996-10-17
Applicant: ABBOTT LAB
Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulae (I); (II); (III) or (IV) wherein A, B, D and E, R , R and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of antibacterial infections with such compositions, and processes for the preparation of the compounds.
-
公开(公告)号:DK0876388T3
公开(公告)日:2004-06-07
申请号:DK96936579
申请日:1996-10-17
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , PHAN LY TAM , CHU DANIEL T , SPINA KENNETH P , HALLAS ROBERT , ELLIOTT RICHARD L
Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulae (I); (II); (III) or (IV) wherein A, B, D and E, R , R and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of antibacterial infections with such compositions, and processes for the preparation of the compounds.
-
公开(公告)号:BR9714269A
公开(公告)日:2000-04-18
申请号:BR9714269
申请日:1997-04-07
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , PHAN LY TAM , CHU DANIEL T , SPINA KENNETH P , HALLAS ROBERT , ELLIOT RICHARD L , TUFANO MICHAEL
IPC: C07H17/00 , A61K31/00 , A61K31/70 , A61K31/7042 , A61K31/7048 , A61P31/00 , A61P31/04 , C07H17/08 , A61K31/71
Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of the formula:wherein A, B, D and E, R1, R2, and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of bacterial infections with such compositions, and processes for the preparation of the compounds.
-
公开(公告)号:MX9803692A
公开(公告)日:1998-09-30
申请号:MX9803692
申请日:1998-05-08
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , PHAN LY TAM , CHU DANIEL T , SPINA KENNETH P , HALLAS ROBERT , ELLIOTT RICHARD L
Abstract: Compuestos, o sales farmacéuticamente aceptables y ésteres de los mismos, de las formulas (I); (II); (III) o (IV), en donde A, B, D, y E, R1, R2, y Z se definen específicamente, que tienen actividad antibacteriana; composiciones farmacéuticas que contienen a estos compuestos; tratamiento de infecciones antibacterianos con dichas composiciones, y procesos para la preparacion de los compuestos.
-
-
-
-
-
-
-
-
-